Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis

被引:45
作者
Barthel, H. Richard
Peniston, John H. [2 ]
Clark, Michael B. [3 ]
Gold, Morris S. [4 ]
Altman, Roy D. [1 ]
机构
[1] Univ Calif Los Angeles, Dept Rheumatol & Immunol, David Geffen Sch Med, Los Angeles, CA 90024 USA
[2] Feasterville Family Hlth Care Ctr, Feasterville, PA 19053 USA
[3] Endo Pharmaceut Inc, Chadds Ford, PA 19317 USA
[4] Novartis Consumer Hlth Inc, Parsippany, NJ 07054 USA
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROXIMAL INTERPHALANGEAL JOINT; DICLOFENAC SODIUM GEL; OF-THE-LITERATURE; 5-YEAR FOLLOW-UP; EROSIVE OSTEOARTHRITIS; IMPLANT ARTHROPLASTY; CHONDROITIN SULFATE; CARDIOVASCULAR RISK; SYMPTOMATIC HAND;
D O I
10.1186/ar2906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Nonsteroidal anti-inflammatory drugs are recommended for the relief of pain associated with hand osteoarthritis (OA) but do not alter the underlying structural changes that contribute to impaired physical function. The current analysis examined the relationship of pain relief with measures of function and global rating of disease in patients with hand OA. Methods: This was a combined analysis of 2 prospective, randomized, double-blind, 8-week, multicenter, parallel-group studies comparing diclofenac sodium 1% gel with placebo gel (vehicle) in patients with radiographically confirmed mild to moderate hand OA. Patients (n = 783) aged = 40 years applied diclofenac sodium 1% gel (2 g) or vehicle to each hand 4 times daily for 8 weeks. Outcome measures included pain intensity assessed on a 100 mm Visual Analog Scale (VAS); the Australian/Canadian Osteoarthritis Hand Index (AUSCAN) subscales for pain, stiffness, and physical function (100 mm VAS); and a global rating of disease (100 mm VAS). Change in VAS pain intensity from baseline to week 8 was categorized (<0%, 0%-<15%, 15%-<30%, 30%-<50%, 50%-<70%, and = 70%) without regard to treatment and compared in each category with the mean change from baseline in each AUSCAN subindex and the global rating of disease. Pearson correlations between changes in outcome measures from baseline to week 8 were calculated. Results: Changes in VAS pain intensity were accompanied by similar changes in AUSCAN scores and global rating of disease. Pearson correlations confirmed significant associations (P < 0.001) between change in VAS pain intensity and changes in AUSCAN pain (correlation coefficient [r] = 0.81), AUSCAN function (r = 0.75), AUSCAN stiffness (r = 0.66), and global rating of disease (r = 0.76). Conclusions: Pain relief correlated with improvements in physical function, stiffness, and global rating of disease in patients with hand OA, irrespective of treatment. This suggests that pain or anticipation of pain inhibits physical function and influences patient perception of disease severity in hand OA. These results also suggest that any intervention to relieve the pain of hand OA may improve function and patient perception of disease severity, despite the absence of a disease-modifying mechanism of action.
引用
收藏
页数:8
相关论文
共 36 条
[1]   Validity, factor structure, and clinical relevance of the AUSCAN Osteoarthritis Hand Index [J].
Allen, KD ;
Jordan, JM ;
Renner, JB ;
Kraus, VB .
ARTHRITIS AND RHEUMATISM, 2006, 54 (02) :551-556
[2]   THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS OF THE HAND [J].
ALTMAN, R ;
ALARCON, G ;
APPELROUTH, D ;
BLOCH, D ;
BORENSTEIN, D ;
BRANDT, K ;
BROWN, C ;
COOKE, TD ;
DANIEL, W ;
GRAY, R ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
IKE, R ;
KAPILA, P ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MCSHANE, DJ ;
MEDSGER, T ;
MICHEL, B ;
MURPHY, W ;
OSIAL, T ;
RAMSEYGOLDMAN, R ;
ROTHSCHILD, B ;
STARK, K ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1990, 33 (11) :1601-1610
[3]   Diclofenac Sodium Gel in Patients with Primary Hand Osteoarthritis: A Randomized, Double-blind, Placebo-controlled Trial [J].
Altman, Roy D. ;
Dreiser, Renee-Liliane ;
Fisher, Chester L. ;
Chase, Walter F. ;
Dreher, Donatus S. ;
Zacher, Josef .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (09) :1991-1999
[4]  
Barkin Robert L, 2004, Am J Ther, V11, P124, DOI 10.1097/00045391-200403000-00007
[5]  
Berner T, 2009, AC NURS PRACT 24 NAT
[6]   Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: The doxycycline trial [J].
Brandt, KD ;
Mazzuca, SA .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2006, 32 (01) :217-+
[7]   Pyrolytic carbon proximal interphalangeal joint arthroplasty: Results with minimum two-year follow-up evaluation [J].
Bravo, Cesar J. ;
Rizzo, Marco ;
Hormel, Kirsten B. ;
Beckenbaugh, Robert D. .
JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2007, 32A (01) :1-11
[8]   Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study) [J].
Dahaghin, S ;
Bierma-Zeinstra, SMA ;
Ginai, AZ ;
Pols, HAP ;
Hazes, JMW ;
Koes, BW .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) :682-687
[9]   Health-related quality of life in total hip and total knee arthroplasty - A qualitative and systematic review of the literature [J].
Ethgen, O ;
Bruyere, O ;
Richy, F ;
Dardennes, C ;
Reginster, JY .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2004, 86A (05) :963-974
[10]   TOPICAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND ADMISSION TO HOSPITAL FOR UPPER GASTROINTESTINAL-BLEEDING AND PERFORATION - A RECORD LINKAGE CASE-CONTROL STUDY [J].
EVANS, JMM ;
MCMAHON, AD ;
MCGILCHRIST, MM ;
WHITE, G ;
MURRAY, FE ;
MCDEVITT, DG ;
MACDONALD, TM .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (6996) :22-26